Safety and Short Term Effectiveness of EEA Versus PPH Stapler for III Degree Hemorrhoids
NCT ID: NCT01413867
Last Updated: 2013-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
120 participants
INTERVENTIONAL
2011-03-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This randomized controlled study was aimed to demonstrate whether the new EEA stapler Covidien was able to resect more quantity of prolapsed mucosa than the traditional PPH 01/03 Ethicol Endosurgery by measuring the surface of the resected specimen and to demonstrate if the modified stapled sutures can ensure better intraoperative hemostasis by measuring the number of overstitches required to get perfect hemostasis during the operation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Randomized Trial Comparing THD Versus Stapler Operation for 3rd Degree Hemorrhoids
NCT00823784
Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids
NCT01306877
Transanal Haemorrhoidal Dearterialisation Versus Stapler Haemorrhoidopexy
NCT01615575
Hemorrhoidal Artery Ligation and Rectoanal Repair Versus Stapled Hemorrhoidopexy
NCT01647763
Comparison Between Excisional Hemorrhoidectomy and Haemorrhoidal Dearterialisation With Anopexy
NCT01263431
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EEA group
Group of patients with III degree hemorrhoids treated by EEA stapler
stapled hemorrhoidopexy
stapled hemorrhoidopexy will be performed using the EEA stapler Covidien
PPH group
group of patients with III degree hemorrhoids treated by PPH stapler
stapled hemorrhoidopexy
stapled hemorrhoidopexy will be performed using the PPH01/03 Ethicon EndoSurgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stapled hemorrhoidopexy
stapled hemorrhoidopexy will be performed using the EEA stapler Covidien
stapled hemorrhoidopexy
stapled hemorrhoidopexy will be performed using the PPH01/03 Ethicon EndoSurgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
* mental ability to understand the procedure
Exclusion Criteria
* Fecal Incontinence
* Chronic inflammatory bowel disease
* Anal sphincter lesions
* coagulative defects
* obstructed defecation
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Societa Italiana di Chirurgia ColoRettale
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Donato F Altomare
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Emergency and Organ transplantation
Bari, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No sponsor
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.